###BASE_URL###

GENET-news articles on GE goats

go to page: 1 2 3 4 5 6

2009-05-11 |

Lundbeck launches drug from DNA-altered goats in the USA

The first drug made using genetically engineered animals has gone on sale in the United States, marketed by the U.S. arm of Lundbeck, the Danish drugmaker said on Wednesday. ATryn is an intravenous anti-clotting therapy made using a human protein gathered from female goats specially bred to produce it in their milk.

2009-04-09 |

Biotech animals case goes to High Court in New Zealand

The High Court case taken by GE Free NZ in food and environment against the Environmental Risk Management Authority (ERMA) and AgResearch a Crown Research Institute (CRI) is being heard on Monday 9th March, 2009. GE Free NZ took the action after AgResearch made a series of four applications that seek to develop, import and commercialise genetically modified animals from nine species of animals (alpacas, buffalo, cows, deer, goats, horses and donkeys, sheep, pigs). The generic applications seek approval at any location and for an indefinite period to allow commercial production of biopharmaceuticals, nutraceuticals and diseased animals for research.

2009-04-09 |

U.S.-Brazilian research team to tackle deadly intestinal diseases with GE goats’ milk

Scientists in Brazil and at the University of California, Davis, are teaming up to develop a herd of genetically modified dairy goats, whose milk is expected to protect against the types of diarrheal diseases that each year claim the lives of more than 2 million children around the world. The team plans to have a milk-producing herd of these goats established in Brazil within two years and hopes to begin human trials with the genetically enhanced goats’ milk within three to five years. The milk will carry increased levels of the human enzyme lysozyme.

2009-02-13 |

More news on GE pharma goats

A research team at UC Davis is hoping to save millions of lives with a product created from bioengineered animals. [...] these animals on the UC Davis campus could be on the forefront of a medical revolution -- preventing diseases that claim millions of lives. ”There are places where one in four kids die before the age of five because of diarrhea. It’s a huge cost to the world,” said James Murray, Ph.D. from UC Davis.

2009-02-09 |

GE goats make drugs, world doesn’t change

Goats can now make medicine in their milk. But they can’t make money...yet. Yesterday the Food and Drug Administration approved Atryn, from GTC Biotherapeutics, a medicine to treat a hereditary deficiency of the clot-preventing chemical antithrombin. It will be the first medicine made in transgenic animals to be sold. Investors shrugged. Shares in the tiny company are worth only 75 cents and the stock market puts the company’s value at a measly $75 million.

2009-01-21 |

GTC and its GE pharma goats partly back in Nasdaq’s good graces

Transgenic therapeutics company GTC Biotherapeutics Inc. reports it has heard from the Listing Qualifications Staff of The Nasdaq Stock Market indicating that the Framingham company has regained compliance with the minimum market value requirement for continued listing on The Nasdaq Capital Market. By exceeding $35 million of market capitalization for 10 consecutive trading days, GTC has cleared one hurdle in its race to keep from being delisted. GTC also has until at least July 20, 2009, to regain compliance with the minimum $1 bid price requirement for stay listed on the Nasdaq market.

2009-01-09 |

Drug manufacturing in bioengineered goats: FDA says it looks safe

Would you take a drug made from the milk of a genetically modified goat? A committee of expert advisers to the FDA will take a swing at that question, weighing the safety and effectiveness of such a treatment on Friday. The U.S. drug regulator is seeking advice on whether to approve an application from Framingham, MA-based GTC Biotherapeutics, a company aiming to prove that the drug it makes in goats, an anti-clotting agent, should be the first transgenic- animal-derived drug cleared for sale in the U.S.

2008-11-14 |

GTC Biotherapeutics producing GE pharma goats delisted from NASDAQ Capital Market

GTC Biotherapeutics, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market indicating that GTC no longer satisfies the minimum $2.5 million stockholders’ equity requirement for continued listing on The NASDAQ Capital Market, as set forth in Marketplace Rule 4310 (c)(3).

2008-11-03 |

Strong support for rally against GM crops in Western Australia surprises backers

A RALLY against the introduction of genetically modified crops drew nearly 1000 people to the steps of the WA Parliament today, organisers have claimed. Farmers attending brought along goats, chickens and even a prize-winning bull, the Conservation Council of WA said.
It said their message was that GM crops not only risked WA’s reputation as a clean, green state but might also have consequences for human health.

2008-09-18 |

Despite a ban, Bt cotton cultivation is widespread in Orissa (India)

THE recent death of 93 goats after grazing near a cotton field in Bolangir, a tribal-dominated district in Orissa, has put the authorities on alert. The field in Kuthurla village, Khaprakhol block, was reportedly under Bt cotton cultivation. The state government discourages cultivation of Bt cotton as a matter of policy. Following the incident, the police arrested one Shankar Deep from the village for allegedly poisoning the goats by sprinkling organophosphate pesticides, a potent neurotoxin, on the field.

go to page: 1 2 3 4 5 6

Home: GENET